We describe a case of hepatitis and warm antibody hemolytic anemia due to dydrogesterone.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Dydrogesterone, similar to women’s natural progesterone, has been used in a wide range of gynecological conditions.
📊
Key Findings & Data:Despite its widespread use, dydrogesterone-induced hepatotoxicity and dydrogesterone-induced hemolytic anemia have, to the best of our knowledge, never been reported previously.
💡
Conclusion & Impact:We describe a case of hepatitis and warm antibody hemolytic anemia due to dydrogesterone.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Anemi · hemolitik · otoimmün
Abstract
Dydrogesterone, similar to women’s natural progesterone, has been used in a wide range of gynecological conditions. Despite its widespread use, dydrogesterone-induced hepatotoxicity and dydrogesterone-induced hemolytic anemia have, to the best of our knowledge, never been reported previously. We describe a case of hepatitis and warm antibody hemolytic anemia due to dydrogesterone.
Özet
Doğal progesterone benzer olan dydrogesterone çeşitli jinekolojik durumlarda kullanılmaktadır. Yaygın bir şekilde kullanılmasına rağmen; bugüne kadar dydrogesterone’un neden olduğu hepatotoksisite ve otoimmün hemolitik anemi bildirilmemiştir. Dydrogesteron’un yol açtığı hepatit ve sıcak antikor pozitif hemolitik anemili bir olguyu sunduk.
ALTINTAŞ, E., OĞUZ, D., KACAR, S., ÖZDERİN, Y., SEZGİN, O., ZENGİN, İ. N. (2004). Didrogesteron'un neden olduğu hepatit ve otoimmün hemolitik anemi. Turkish Journal of Gastroenterology, Cilt: 15 - Sayı: 1, 49–52. https://ajindex.com/articles/411471
Kuhl H. Effects of progesterone on homeostasis. Maturitas 1996; 24: 1-19
Kreek MJ. Female sex steroids and cholestasis. Semin Li ver Dis 1987; 7: 8-23
Schenker S, Martin RR, Hoyumpa AM. Antecedent liver di sease and drug toxicity. J Hepatol 1999; 31: 1098-105
Dansette PM, Bonierbale E, Minoletti C, et al. Drug indu ced immunotoxicity. Eur J Drug Metab Pharmacokinet 1998; 23: 443-51
Bissel DM, Gores GJ, Laskin DL, Hoofnagle JH. Drug in duced liver injury: mechanism and test systems. Hepato- logy 2001; 33: 1009-13
Manns MP, Straub PO. Cytochrome P450 and uridine trip- hosphate glucuronosyltransferases: model autotantigens to study drug induced, virus induced, and autoimmune liver disease. Hepatology 1997; 26: 1054-67
Robin MA, Maratrat M, Le Roy M, et al. Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2Cll-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human se ra. J Clin Invest 1996; 98: 1471-80
Beaune PH, Lecoeur S, Bourdi M, et al. Anti-cytochrome P450 autoantibodies in drug-induced disease. Eur J Ha- ematol Suppl 1996; 60: 89-92
Larry D. Drug induced liver disease. J Hepatol 2000; 32: 77-88
Stahl D, Lacroix-Desmazes S, Heudes D, et al. Altered control of self-reactive IgG by autologous IgM in patients with warm autoimmune hemolytic anemia. Blood 2000; 95: 328-35
Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med 1998; 339: 1217-27.